Clinical Trials for Sangamo Therapeutics

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sangamo Therapeutics

Clinical Trials (7)

NCT06980948
Safety and Tolerability Study of ST-503 for Small Fiber Neuropathy-associated Refractory Pain
PHASE1Recruiting
27 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor10 locations
NCT05987527
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
N/AEnrolling by invitation
11 participants
Started: Aug 15, 2023 · Completed: Jun 11, 2039
2 conditions1 sponsor5 locations
NCT05145062
Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.
N/AEnrolling by invitation
12 participants
Started: Dec 21, 2021 · Completed: Jul 14, 2038
1 condition1 sponsor7 locations
NCT05039866
Long-Term Follow-up of Subjects Who Were Treated With ST-920
N/AEnrolling by invitation
48 participants
Started: Aug 16, 2021 · Completed: Mar 31, 2039
2 conditions1 sponsor13 locations
NCT04817774
Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
PHASE1/PHASE2Active, not recruiting
26 participants
Started: Mar 17, 2021 · Completed: Oct 29, 2025
2 conditions1 sponsor5 locations
NCT04628871
Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX
N/AActive, not recruiting
13 participants
Started: Nov 3, 2020 · Completed: Jan 1, 2030
3 conditions1 sponsor5 locations
NCT02500849
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
PHASE1Active, not recruiting
12 participants
Started: Mar 10, 2016 · Completed: Aug 24, 2026
1 condition3 sponsors5 locations